Rolf Dach

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 7 EPO patents. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim Kg. Active years: 1996-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolf Dach. Retrieved from https://idiyas.com/inventor/rolf-dach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

5 out of 1,561

Boehringer Ingelheim International Gmbh

patents

3 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

1 out of 197

Boehringer Ingelheim Kg

patents

4. 1 out of 149

Boehringer Ingelheim Pharma Kg

patents

Years Active: 1996-2015

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8993778 - Process for manufacture of telmisartan (2015-03-31),

2. 8993770 - Process for the manufacture of dabigatran etexilate (2015-03-31),

3. 8513413 - Process for the preparation of nitroorotic acid (2013-08-20),

4. 8399678 - Process for the manufacture of dabigatran etexilate (2013-03-19),

5. 8263788 - Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions (2012-09-11),

6. 7608722 - [object Object] (2009-10-27),

7. 7193089 - Process for manufacture of telmisartan (2007-03-20),

8. 6770762 - Process for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole (2004-08-03),

9. 6403790 - Process for the production of epinastine hydrochloride in the high-melting crystal modification (2002-06-11),

10. 5510484 - Process for preparing 1,3-dimethy-4,5-diaminouracil (1996-04-23),

Title: Rolf Dach: Innovator in Pharmaceutical Processes

Introduction

Rolf Dach is a notable inventor based in Gau-Algesheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for manufacturing important compounds. With a total of 10 patents to his name, Dach's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents, Rolf Dach has developed a process for the manufacture of dabigatran etexilate. This improved process focuses on preparing dabigatran etexilate and analogous compounds effectively. Additionally, he has patented a process for manufacturing telmisartan, which involves a reaction between specific chemical compounds to yield a crucial intermediate, followed by hydrolysis to obtain the final acid function.

Career Highlights

Throughout his career, Rolf Dach has worked with prominent companies in the pharmaceutical sector, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His expertise in pharmaceutical processes has positioned him as a valuable asset in the development of innovative drug manufacturing techniques.

Collaborations

Rolf Dach has collaborated with esteemed colleagues such as Helmut Heitger and Frieder Gnad. These partnerships have further enhanced his contributions to the field and facilitated the advancement of pharmaceutical innovations.

Conclusion

Rolf Dach's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving drug manufacturing processes, ultimately benefiting healthcare and patient outcomes.

Profile summary based on public USPTO records.